Clinical trial

Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage…

NCT00309972 · University College, London, Other · Completed

Key facts

NCT number NCT00309972
Title Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Official title A Randomized Phase III Trial of Sequential Chemotherapy Followed By Radical Radiotherapy Versus Concurrent Chemo-Radiotherapy Followed by Chemotherapy in Patients With Inoperable Stage III Non-Small Cell Lung Cancer and Good Performance Status
Acronym SOCCAR
Lead sponsor University College, London, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Lung Cancer
Intervention type Drug
Interventions Control arm (SEQ):, Experimental arm (CON):
Enrollment 130
Start date Dec 1, 2005
Primary completion Feb 1, 2011
Completion Feb 1, 2012
First posted Apr 3, 2006
Last update posted Dec 3, 2014
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies